BrightGene Bio-Medical Technology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 8.71% vs -7.01% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 478.95% vs 69.64% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "353.20",
          "val2": "324.90",
          "chgp": "8.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "117.00",
          "val2": "54.30",
          "chgp": "115.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.10",
          "val2": "18.60",
          "chgp": "8.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "16.10",
          "val2": "2.60",
          "chgp": "519.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "55.00",
          "val2": "9.50",
          "chgp": "478.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "202.20%",
          "val2": "26.80%",
          "chgp": "17.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.66% vs 8.63% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -73.81% vs -18.51% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,220.00",
          "val2": "1,279.60",
          "chgp": "-4.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.50",
          "val2": "310.70",
          "chgp": "-34.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "63.90",
          "val2": "53.80",
          "chgp": "18.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "10.70",
          "val2": "-10.10",
          "chgp": "205.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.00",
          "val2": "141.30",
          "chgp": "-73.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.20%",
          "val2": "150.80%",
          "chgp": "-12.06%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

353.20

324.90

8.71%

Operating Profit (PBDIT) excl Other Income

117.00

54.30

115.47%

Interest

20.10

18.60

8.06%

Exceptional Items

16.10

2.60

519.23%

Consolidate Net Profit

55.00

9.50

478.95%

Operating Profit Margin (Excl OI)

202.20%

26.80%

17.54%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 8.71% vs -7.01% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 478.95% vs 69.64% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,220.00

1,279.60

-4.66%

Operating Profit (PBDIT) excl Other Income

204.50

310.70

-34.18%

Interest

63.90

53.80

18.77%

Exceptional Items

10.70

-10.10

205.94%

Consolidate Net Profit

37.00

141.30

-73.81%

Operating Profit Margin (Excl OI)

30.20%

150.80%

-12.06%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -4.66% vs 8.63% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -73.81% vs -18.51% in Dec 2024

All Annual Results